M
MRNA icon

Mirova’s Moderna MRNA Stock Holding History

Mirova’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-741
Closed -$79K – 141
2024
Q1 		$79K Hold
741
– – 0.01% 124
2023
Q4 		$73.7K Sell
741
-44
-6% -$3.7K 0.02% 115
2023
Q3 		$81.1K Sell
785
-1,274
-62% -$142K 0.02% 110
2023
Q2 		$250K Sell
2,059
-2,212
-52% -$295K 0.04% 115
2023
Q1 		$656K Buy
4,271
+2,488
+140% +$410K 0.09% 97
2022
Q4 		$320K Sell
1,783
-1,783
-50% -$292K 0.05% 135
2022
Q3 		$421K Sell
3,566
-2,503
-41% -$380K 0.07% 125
2022
Q2 		$866K Sell
6,069
-3,634
-37% -$519K 0.12% 100
2022
Q1 		$1.67M Sell
9,703
-234
-2% -$39.4K 0.22% 62
2021
Q4 		$2.52M Buy
+9,937
New +$2.91M 0.3% 48

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mirova's MRNA Position: Q2 2024 in Review

Mirova sold out of Moderna (MRNA) in Q2 2024, closing a stake of 741 shares — an estimated $79K sold.

Mirova first reported a position in MRNA in Q4 2021 and held it in 10 quarters. The position peaked at $2.52M in Q4 2021. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Mirova reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Mirova sold 741 Moderna shares in Q2 2024, an estimated $79K.
  • Mirova first reported a position in Moderna in Q4 2021 and held it in 10 quarters.
  • Mirova's Moderna position peaked at $2.52M in Q4 2021.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.